Advertisement

Citation tools

Kwong, Yok-Lam et al "PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase." Blood (2017): blood-2016-12-756841. Web. 21 Feb. 2017.